Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models

D Ezhilarasan - Environmental Toxicology and Pharmacology, 2023 - Elsevier
Thioacetamide (TAA) undergoes bioactivation in the liver by the CYP450 2E1 enzyme,
resulting in the formation of TAA-S-oxide and TAA-S-dioxide. TAA-S-dioxide induces …

Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models

D Ezhilarasan - Environmental Toxicology and …, 2023 - ui.adsabs.harvard.edu
Thioacetamide (TAA) undergoes bioactivation in the liver by the CYP450 2E1 enzyme,
resulting in the formation of TAA-S-oxide and TAA-S-dioxide. TAA-S-dioxide induces …

Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models

D Ezhilarasan - Environmental toxicology and …, 2023 - pubmed.ncbi.nlm.nih.gov
Thioacetamide (TAA) undergoes bioactivation in the liver by the CYP450 2E1 enzyme,
resulting in the formation of TAA-S-oxide and TAA-S-dioxide. TAA-S-dioxide induces …

Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models.

D Ezhilarasan - Environmental Toxicology and Pharmacology, 2023 - europepmc.org
Thioacetamide (TAA) undergoes bioactivation in the liver by the CYP4502E1 enzyme,
resulting in the formation of TAA-S-oxide and TAA-S-dioxide. TAA-S-dioxide induces …